Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Precision Optics Corporation, Inc. Common stock (POCI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: POCI (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -27.86% | Avg. Invested days 41 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 37.72M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.21 | 52 Weeks Range 3.47 - 6.59 | Updated Date 06/29/2025 |
52 Weeks Range 3.47 - 6.59 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.91 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -32.84% | Operating Margin (TTM) -48.69% |
Management Effectiveness
Return on Assets (TTM) -18.31% | Return on Equity (TTM) -47.37% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 36585163 | Price to Sales(TTM) 2.14 |
Enterprise Value 36585163 | Price to Sales(TTM) 2.14 | ||
Enterprise Value to Revenue 2.08 | Enterprise Value to EBITDA -27.04 | Shares Outstanding 7666250 | Shares Floating 5681226 |
Shares Outstanding 7666250 | Shares Floating 5681226 | ||
Percent Insiders 22.65 | Percent Institutions 31.47 |
Upturn AI SWOT
Precision Optics Corporation, Inc. Common stock
Company Overview
History and Background
Precision Optics Corporation, Inc. (POCI) was founded in 1982. It specializes in the design, development, and manufacturing of advanced optical systems and components.
Core Business Areas
- Micro-Optics: High-precision micro-optics used in medical and defense applications.
- Defense & Security: Custom optical systems for military and security applications, including surveillance and targeting.
- Medical Devices: Optical components and systems for minimally invasive surgical devices and diagnostics.
Leadership and Structure
Mark A. Conte is the CEO. The company has a functional organizational structure with departments specializing in engineering, manufacturing, sales, and marketing.
Top Products and Market Share
Key Offerings
- Competitors: Olympus,Karl Storz,Stryker
- Endoscopic Lenses: Miniature lenses used in endoscopes for minimally invasive surgery. Competitors include Olympus, Karl Storz, and Stryker. Revenue data not publicly available.
- Competitors: L3Harris,Thales,Teledyne
- Targeting Optics: Precision optical systems used in defense applications for targeting and surveillance. Market share data not publicly available. Competitors include L3Harris, Thales, and Teledyne.
Market Dynamics
Industry Overview
The precision optics industry is driven by advancements in medical technology, defense, and industrial automation. Demand is increasing for high-performance optical components in these sectors.
Positioning
Precision Optics positions itself as a provider of highly customized, high-performance optical solutions for niche applications. Its competitive advantage lies in its engineering expertise and ability to meet demanding specifications.
Total Addressable Market (TAM)
The total addressable market for precision optics is estimated to be in the billions of dollars annually. POCI focuses on specific segments within this large market, targeting opportunities where its expertise in custom solutions can provide a competitive advantage.
Upturn SWOT Analysis
Strengths
- Strong engineering capabilities
- Custom design expertise
- Established relationships with key customers
- High-precision manufacturing capabilities
Weaknesses
- Limited scale compared to larger competitors
- Dependence on a few key customers
- Volatile revenue due to project-based business
- Small market capitalization
Opportunities
- Growing demand for minimally invasive surgical devices
- Increasing defense spending on advanced optics
- Expansion into new markets and applications
- Strategic partnerships and acquisitions
Threats
- Competition from larger optical component manufacturers
- Economic downturn impacting defense and medical spending
- Technological obsolescence
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- L3Harris Technologies (LHX)
- Teledyne Technologies (TDY)
- Olympus Corp (OCPNY)
- Thales (THLEF)
Competitive Landscape
Precision Optics competes with larger, more established companies. Its competitive advantage lies in its ability to provide highly customized solutions for niche applications. It needs to continue innovating and expanding its customer base to remain competitive.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been inconsistent due to the project-based nature of the business.
Future Projections: Future growth is dependent on securing new contracts and expanding into new markets. Analyst estimates vary widely.
Recent Initiatives: Recent initiatives include expanding into new medical device applications and investing in new manufacturing capabilities.
Summary
Precision Optics is a niche player in the precision optics market, specializing in custom solutions. The company's strength lies in its engineering expertise and manufacturing capabilities. However, it faces challenges related to its small size, dependence on a few key customers, and the volatile nature of its project-based business model. Future success depends on securing new contracts, expanding into new markets, and managing costs effectively.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings (10-K, 10-Q)
- Industry Reports
- Market Analysis Reports
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It is not financial advice. Investment decisions should be based on individual due diligence and consultation with a qualified financial advisor. Market share data is based on best available estimates and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Precision Optics Corporation, Inc. Common stock
Exchange NASDAQ | Headquaters Gardner, MA, United States | ||
IPO Launch date 1992-01-16 | CEO, President, Treasurer & Director Dr. Joseph N. Forkey | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 83 | Website https://www.poci.com |
Full time employees 83 | Website https://www.poci.com | ||
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies for industrial and military use. It markets its products to medical device companies. Precision Optics Corporation, Inc. was incorporated in 1982 and is based in Gardner, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.